Committee Testimony and Witness Signup
HB0995 - Workgroup to Study the Rise in Adverse Decisions in the State Health Care System - Establishment
Health and Government Operations 2/13/2025 1:00:00 PM
Finance 3/19/2025 1:00:00 PM
As of: 4/30/2025 10:07:59 AM
Name | Organization | Position | Testimony | Committee |
---|---|---|---|---|
Delegate Pena-Melnyk, Delegate Pena-Melnyk | FAV |
In Person - Oral Testimony |
HGO | |
Doherty, Daniel | Maryland State Dental Association, Maryland Society of Oral & Maxillofacial Surgeons | FAV | No Testimony | HGO |
Plante, Cecilia | Maryland Legislative Coalition | FAV | HB0995_Workgroup_to_Study_the_Rise_in_Adverse_Deci | HGO |
Shattuck, Daniel | Brocato & Shattuck | FAV |
In Person - Oral Testimony |
HGO |
Celentano, Matthew | The League of Life and Health Insurers of Maryland | FWA | DOCS-#238721-v1-HB_995_League_FWA.pdf | HGO |
Coleman, Ryan | President, Randallstown NAACP | FAV | No Testimony | HGO |
Kauffman, Danna | FAV |
In Person - Oral Testimony |
HGO | |
Elliott, Robyn | FWA |
In Person - Oral Testimony 2025 MCHS HB 995 House Side.pdf |
HGO | |
Johnson, Deron | Amgen | FAV | No Testimony | HGO |
Peña-Melnyk, Chair Joseline | FAV | Peña-Melnyk - FWA - HB 995 2025 | HGO | |
Routson, Kimberly | MedStar Health | FAV | HB 995 - Workgroup to Study the Rise in Adverse De | HGO |
Meyerovich, Mark | FAV | No Testimony | HGO | |
Williams, Irnise | OAG | FWA | HB995 Workgroup Adverse Decisions LOS Final.pdf | HGO |
(MD), State of Maryland | FAV | HB995- HSCRC - HGO - LOS.pdf | HGO | |
Grant, Marie | Maryland Insurance Administration | FAV |
In Person - Oral Testimony HB 995 - MIA - Support.pdf |
HGO |
Nicklas, Andrew | Maryland Hospital Association | FAV |
In Person - Oral Testimony HB0995 - Workgroup to Study the Rise in Adverse De |
HGO |
Kaplowitz, Richard KAP | Year | FAV | Testimony in support of HB0995 - Workgroup to Stud | HGO |
Bayless, Victoria | Luminis Health Anne Arundel Medical Center | FAV |
In Person - Oral Testimony |
HGO |
Schnittger, Stephanie | Luminis Health | FAV |
In Person - Oral Testimony |
HGO |
Peters, Sarah | Maryland Podiatric Medical Association | FAV | Maryland Podiatric Medical Association FAV | HGO |
Delegate Pena-Melnyk, Delegate Pena-Melnyk | FAV |
In Person - Oral Testimony |
FIN | |
Searcy, Talisha | City of Takoma Park | FAV | NCADD-MD - 2025 HB 995 FAV - Adverse Decisions Wor | FIN |
Williams, Irnise | OAG | FAV | HB995 Workgroup Adverse Decisions LOS (1).pdf | FIN |
Meyerovich, Mark | FAV | No Testimony | FIN | |
Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - 2025 HB 995 FAV - Adverse Decisions Wor | FIN |
(MD), State of Maryland | FWA | HB 995 - FIN - HSCRC - LOSA.pdf | FIN | |
Kaplowitz, Richard KAP | Year | FWA | HB0995 crossfile FWA - Workgroup to Study the Rise | FIN |
Hudson, Lee | Delaware-Maryland Synod, ELCA | FAV | No Testimony | FIN |
Elliott, Robyn | American College of Nurse Midwives -Maryland Affiliate | FAV | 2025 MdAPA HB 995 Senate Side.pdf | FIN |
Navabi, Jennifer | Maryland Academy of Physician Assistants | FAV | 2025 MdAPA HB 995 Senate Side.pdf | FIN |
Elliott, Robyn | FAV | No Testimony | FIN | |
Navabi, Jennifer | Maryland Community Health System | FAV | 2025 MCHS HB 995 Senate Side.pdf | FIN |
Elliott, Robyn | FAV | No Testimony | FIN | |
Whitaker, Jake | Maryland Hospital Association | FAV | Crossover Testimony-HB 995-Workgroup to Study the | FIN |
Plante, Cecilia | Maryland Legislative Coalition | FAV | HB0995_Workgroup_to_Study_the_Rise_in_Adverse_Deci | FIN |
MacMillan, Jacqueline (Jackie) | FWA | Testimony on HB995 - Google Docs.pdf | FIN | |
Grant, Marie | Maryland Insurance Administration | FAV | HB 995 - MIA - FAV - FIN.pdf | FIN |
Waheed, Fatima | FWA |
In Person - Oral Testimony |
FIN | |
Delph, Yvette | FWA | HB-995–Testimony-YDelph.pdf | FIN | |
Puentes, Erica | Progressive Maryland | FWA |
In Person - Oral Testimony Progressive Maryland’s Testimony on HB995 for Sena |
FIN |
Testimony, All | N/A | Merged Testimony as of 3-17-2025 at 818 PM | FIN |
Validation
Please fix the following:
MyMGA
Accessibility Tools